JPRN-UMIN000025090
Completed
未知
The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy - The clinical trial to evaluate the efficacy of [11C]K-2 in epilepsy patients
Yokohama City University, School of Medicine0 sites8 target enrollmentDecember 1, 2016
Conditionsrefractory epilepsy patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- refractory epilepsy patients
- Sponsor
- Yokohama City University, School of Medicine
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.patients who have significant abnormalities insides the brains 2\.patients who have experienced the electric stimulation therapy 3\.patients who undergo artificial dialysis 4\.patients who have severe liver dysfunction 5\.patients who have tatoo 6\.claustrophobic patients 7\.breast\-feeding mothers, expecting mothers, females who desire to be a mother 8\.patients who desire to bear a child within this study period 9\.patients who take Fycompa 10\.patients who underwent nuclear medicine examination within one\-week before this registarion 11\.patients who underwent other clinical trials using unapproved nuclear medicine examination within six month before this registarion 12\.patients who underwent other clinical trials within 12 weeks before this registarion 13\.patients whom study doctors consider unappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
To study the efficacy of toothpastes in teeth sensitivityHealth Condition 1: K038- Other specified diseases of hard tissues of teethCTRI/2018/04/013038Dabur India Limited139
Active, not recruiting
Not Applicable
The effectiveness and safety of oral adhesive bandage for extraction wound managementWound management in tooth extractionOral HealthISRCTN11589028Wuhan University120
Completed
Not Applicable
A clinical trial to investigate the efficacy and safety of video-laryngoscopes for education of tracheal intubatioJPRN-UMIN000011477Department of Anesthesiology and Critical Care, Hiroshima University Hospital500
Recruiting
Phase 3
Thalidomide effects in COVID-19Covid 19.Covid 19IRCT20110423006257N3Arak University of Medical Sciences66
Completed
Not Applicable
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesPrimary immunodeficiency diseases (PID)Haematological DisordersCommon variable immunodeficiencyISRCTN05425999Octapharma AG (Switzerland)50